These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 27423037)
1. Design and characterization of highly in vitro antitumor active ternary copper(II) complexes containing 2'-hydroxychalcone ligands. Křikavová R; Vančo J; Trávníček Z; Hutyra J; Dvořák Z J Inorg Biochem; 2016 Oct; 163():8-17. PubMed ID: 27423037 [TBL] [Abstract][Full Text] [Related]
2. Two new ternary complexes of copper(II) with tetracycline or doxycycline and 1,10-phenanthroline and their potential as antitumoral: cytotoxicity and DNA cleavage. Silva PP; Guerra W; Silveira JN; Ferreira AM; Bortolotto T; Fischer FL; Terenzi H; Neves A; Pereira-Maia EC Inorg Chem; 2011 Jul; 50(14):6414-24. PubMed ID: 21692452 [TBL] [Abstract][Full Text] [Related]
3. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties. Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461 [TBL] [Abstract][Full Text] [Related]
4. Iron-salophen complexes involving azole-derived ligands: A new group of compounds with high-level and broad-spectrum in vitro antitumor activity. Vančo J; Šindelář Z; Dvořák Z; Trávníček Z J Inorg Biochem; 2015 Jan; 142():92-100. PubMed ID: 25450023 [TBL] [Abstract][Full Text] [Related]
5. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4). Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, and antitumor activity of three ternary dinuclear copper (II) complexes with a reduced Schiff base ligand and diimine coligands in vitro and in vivo. Jia L; Xu J; Zhao X; Shen S; Zhou T; Xu Z; Zhu T; Chen R; Ma T; Xie J; Dong K; Huang J J Inorg Biochem; 2016 Jun; 159():107-19. PubMed ID: 26974885 [TBL] [Abstract][Full Text] [Related]
7. Antioxidant, DNA interaction, VEGFR2 kinase, topoisomerase I and in vitro cytotoxic activities of heteroleptic copper(II) complexes of tetrazolo[1,5-a]pyrimidines and diimines. Haleel A; Mahendiran D; Veena V; Sakthivel N; Rahiman AK Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():366-382. PubMed ID: 27524032 [TBL] [Abstract][Full Text] [Related]
8. Fluorescent mixed ligand copper(II) complexes of anthracene-appended Schiff bases: studies on DNA binding, nuclease activity and cytotoxicity. Jaividhya P; Ganeshpandian M; Dhivya R; Akbarsha MA; Palaniandavar M Dalton Trans; 2015 Jul; 44(26):11997-2010. PubMed ID: 26076117 [TBL] [Abstract][Full Text] [Related]
9. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity. Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, DNA interaction and cleavage, and in vitro cytotoxicity of copper(II) mixed-ligand complexes with 2-phenyl-3-hydroxy-4(1H)-quinolinone. Buchtík R; Trávníček Z; Vančo J; Herchel R; Dvořák Z Dalton Trans; 2011 Oct; 40(37):9404-12. PubMed ID: 21842058 [TBL] [Abstract][Full Text] [Related]
12. Heteroleptic copper(II) complexes of prenylated flavonoid osajin behave as selective and effective antiproliferative and anti-inflammatory agents. Vančo J; Trávníček Z; Hošek J; Dvořák Z J Inorg Biochem; 2022 Jan; 226():111639. PubMed ID: 34717252 [TBL] [Abstract][Full Text] [Related]
13. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis. Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566 [TBL] [Abstract][Full Text] [Related]
14. Cu(II)-dipeptide complexes of 2-(4'-thiazolyl)benzimidazole: synthesis, DNA oxidative damage, antioxidant and in vitro antitumor activity. Fu XB; Zhang JJ; Liu DD; Gan Q; Gao HW; Mao ZW; Le XY J Inorg Biochem; 2015 Feb; 143():77-87. PubMed ID: 25528481 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, structural characterization, cytotoxic properties and DNA binding of a dinuclear copper(II) complex. Ferreira BJ; Brandão P; Meireles M; Martel F; Correia-Branco A; Fernandes DM; Santos TM; Félix V J Inorg Biochem; 2016 Aug; 161():9-17. PubMed ID: 27157979 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems? Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390 [TBL] [Abstract][Full Text] [Related]
17. Ferrocene-conjugated L-tryptophan copper(II) complexes of phenanthroline bases showing DNA photocleavage activity and cytotoxicity. Goswami TK; Chakravarthi BV; Roy M; Karande AA; Chakravarty AR Inorg Chem; 2011 Sep; 50(17):8452-64. PubMed ID: 21797197 [TBL] [Abstract][Full Text] [Related]
18. In vitro DNA and BSA-binding, cell imaging and anticancer activity against human carcinoma cell lines of mixed ligand copper(II) complexes. Anjomshoa M; Torkzadeh-Mahani M Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():390-402. PubMed ID: 26057093 [TBL] [Abstract][Full Text] [Related]